TriSalus Life Sciences Income Statement (2022-2025) | TLSI

Income Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 3.92M3.23M2.98M4.61M5.19M5.72M6.46M7.36M7.35M8.26M9.17M11.21M11.57M
Cost of Revenue 3.03M3.86M3.25M3.49M4.69M5.60M6.69M6.00M6.14M7.01M6.73M7.16M6.84M
Gross Profit 3.22M2.41M2.32M3.84M4.60M5.14M5.49M6.45M6.34M7.04M7.67M9.41M9.66M
Operating items
Research & Development 4.81M6.27M5.64M6.89M9.51M7.77M5.84M4.67M4.22M2.96M3.30M3.92M5.18M
Selling, General & Administrative 0.67M0.29M3.50M4.06M3.55M4.90M9.03M6.01M4.63M3.96M4.73M4.66M4.97M5.66M6.66M
Operating Expenses 0.67M0.29M8.30M10.32M9.19M11.78M18.53M13.78M10.47M8.62M8.95M7.62M8.27M9.58M11.84M
Operating Income -0.67M-0.29M-8.11M-11.77M-10.12M-11.43M-18.62M-14.25M-11.67M-8.17M-8.74M-7.58M-7.33M-7.33M-9.01M
EBIT -0.67M-0.29M-8.11M-11.77M-10.12M-11.43M-18.62M-14.25M-11.67M-8.17M-8.74M-7.58M-7.33M-7.33M-9.01M
Non-operating items
Interest & Investment Income 0.06M0.31M0.05M0.10M0.04M0.04M0.12M0.24M0.09M0.10M0.16M0.06M0.07M0.13M0.17M
Other Non Operating Income -0.03M-2.12M2.42M0.62M0.02M-0.15M-0.04M-0.01M-0.10M-0.25M-0.04M-0.09M
Non Operating Income 3.51M2.70M-0.03M-0.35M-0.02M-0.03M-0.01M-0.32M-0.15M-0.04M-0.01M-0.10M-0.25M-0.04M-0.09M
Net income details
EBT 2.84M2.41M-8.09M-22.54M-8.27M-13.96M-1.43M-35.64M-13.20M-4.33M-2.40M-10.11M-10.37M-8.29M-10.81M
Tax Provisions 0.03M0.01M-0.01M0.01M0.00M0.00M0.01M-0.00M-0.00M0.01M-0.00M0.01M
Profit After Tax 2.84M2.39M-8.09M-22.54M-8.27M-13.97M-1.43M-35.64M-13.21M-4.33M-2.40M-10.11M-10.38M-8.29M-10.81M
Income from Continuing Operations 2.84M2.39M-8.09M-22.54M-8.27M-13.97M-1.43M-35.64M-13.21M-4.33M-2.40M-10.11M-10.38M-8.29M-10.81M
Consolidated Net Income 2.84M2.39M-8.09M-22.54M-8.27M-13.97M-1.43M-35.64M-13.21M-4.33M-2.40M-10.11M-10.38M-8.29M-10.81M
Income towards Parent Company 2.84M2.39M-8.09M-22.54M-8.27M-13.97M-1.43M-35.64M-13.21M-4.33M-2.40M-10.11M-10.38M-8.29M-10.81M
Preferred Dividend Payments 0.46M0.80M0.80M0.80M0.80M0.78M0.71M0.71M11.95M
Net Income towards Common Stockholders 2.27M1.91M-8.09M-25.37M-9.23M-16.00M-1.88M-36.44M-14.01M-5.13M-3.20M-10.89M-11.09M-9.00M-41.27M
Additional items
EPS (Basic) 0.090.08-25.95-79.38-0.57-35.84-0.14-1.05-0.60-0.21-0.12-0.43-0.39-0.27-0.96
EPS (Weighted Average and Diluted) 0.090.08-25.95-79.38-0.57-35.84-0.14-1.05-0.60-0.21-0.12-0.43-0.39-0.27-0.96
Shares Outstanding (Weighted Average) 25.00M25.00M0.31M0.31M16.17M0.45M13.17M9.40M23.32M23.90M26.50M25.33M28.53M32.90M43.06M
Shares Outstanding (Diluted Average) 25.00M25.00M0.31M0.31M16.17M0.45M13.17M9.40M23.32M23.90M26.50M25.33M28.53M32.90M43.06M
EBITDA -0.67M-0.29M-8.11M-11.77M-10.12M-11.43M-18.62M-14.25M-11.67M-8.17M-8.74M-7.58M-7.33M-7.33M-9.01M
Interest Expenses 0.00M0.01M0.00M0.00M0.00M0.00M0.88M1.14M1.07M1.21M1.42M1.46M
Tax Rate 1.17%-0.03%0.06%-0.09%0.00%-0.02%-0.16%0.12%0.01%-0.05%0.04%-0.05%